Interleukin-1 receptor-associated kinase 1 controls chemoresistance and immuno-killing in non-small cell lung cancer

Sabrina Digiovanni, Claudia Giannotta, Luca Alessandri, Simona Fontana, Angelo Meoli, Paolo Bironzo, Alessandra Merlini, Gabriella Doronzo, Parab Sushant, Elisa Balmas, Muhlis Akman, Joanna Kopecka, Maddalena Arigoni, Francesca Napoli, Julia Wens, Samuele Tarallo, Alessandro Bertero, Stefano Guglielmo, Barbara Rolando, Davide Palma, Luisella Righi, Massimo Massaia, Raffaele Calogero, Federico Bussolino, Silvia Novello, Giorgio Vittorio Scagliotti, Iris Chiara Salaroglio, Chiara Riganti

Open source

DOI
10.1038/s41392-026-02848-5
Published
2026-09-15
Container
Signal Transduction and Targeted Therapy
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41392-026-02848-5,
  title = {Interleukin-1 receptor-associated kinase 1 controls chemoresistance and immuno-killing in non-small cell lung cancer},
  author = {Sabrina Digiovanni and Claudia Giannotta and Luca Alessandri and Simona Fontana and Angelo Meoli and Paolo Bironzo and Alessandra Merlini and Gabriella Doronzo and Parab Sushant and Elisa Balmas and Muhlis Akman and Joanna Kopecka and Maddalena Arigoni and Francesca Napoli and Julia Wens and Samuele Tarallo and Alessandro Bertero and Stefano Guglielmo and Barbara Rolando and Davide Palma and Luisella Righi and Massimo Massaia and Raffaele Calogero and Federico Bussolino and Silvia Novello and Giorgio Vittorio Scagliotti and Iris Chiara Salaroglio and Chiara Riganti},
  year = {2026},
  journal = {Signal Transduction and Targeted Therapy},
  doi = {10.1038/s41392-026-02848-5},
  url = {https://doi.org/10.1038/s41392-026-02848-5}
}

RIS

TY  - JOUR
TI  - Interleukin-1 receptor-associated kinase 1 controls chemoresistance and immuno-killing in non-small cell lung cancer
AU  - Sabrina Digiovanni
AU  - Claudia Giannotta
AU  - Luca Alessandri
AU  - Simona Fontana
AU  - Angelo Meoli
AU  - Paolo Bironzo
AU  - Alessandra Merlini
AU  - Gabriella Doronzo
AU  - Parab Sushant
AU  - Elisa Balmas
AU  - Muhlis Akman
AU  - Joanna Kopecka
AU  - Maddalena Arigoni
AU  - Francesca Napoli
AU  - Julia Wens
AU  - Samuele Tarallo
AU  - Alessandro Bertero
AU  - Stefano Guglielmo
AU  - Barbara Rolando
AU  - Davide Palma
AU  - Luisella Righi
AU  - Massimo Massaia
AU  - Raffaele Calogero
AU  - Federico Bussolino
AU  - Silvia Novello
AU  - Giorgio Vittorio Scagliotti
AU  - Iris Chiara Salaroglio
AU  - Chiara Riganti
PY  - 2026
JO  - Signal Transduction and Targeted Therapy
DO  - 10.1038/s41392-026-02848-5
UR  - https://doi.org/10.1038/s41392-026-02848-5
ER  - 

APA

Digiovanni, S., Giannotta, C., Alessandri, L., Fontana, S., Meoli, A., Bironzo, P., Merlini, A., Doronzo, G., Sushant, P., Balmas, E., Akman, M., Kopecka, J., Arigoni, M., Napoli, F., Wens, J., Tarallo, S., Bertero, A., Guglielmo, S., Rolando, B., Palma, D., Righi, L., Massaia, M., Calogero, R., Bussolino, F., Novello, S., Scagliotti, G. V., Salaroglio, I. C., & Riganti, C. (2026). Interleukin-1 receptor-associated kinase 1 controls chemoresistance and immuno-killing in non-small cell lung cancer. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-026-02848-5

Source records